Harvard Bioscience (HBIO) Other Operating Expenses (2010 - 2026)

Harvard Bioscience (HBIO) has 17 years of Other Operating Expenses data on file, last reported at $3.2 million in Q1 2026.

• On a quarterly basis, Other Operating Expenses fell 93.84% year-over-year to $3.2 million in Q1 2026; TTM through Mar 2026 was $7.9 million, a 87.42% decrease from a year earlier, with the FY2025 full-year figure at $61.5 million, up 256.25% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $3.2 million, up from -$4.2 million in the prior quarter.
• Over the last five years, Other Operating Expenses for HBIO reached as high as $51.6 million in Q1 2025 and fell as low as -$4.7 million in Q4 2023.
• Historically, Other Operating Expenses has averaged $6.8 million across 5 years, with a median of $4.5 million in 2022.
• On a YoY basis, Other Operating Expenses climbed as much as 895.43% in 2025 and fell as far as 211.28% in 2025.
• Year by year, Other Operating Expenses stood at $4.5 million in 2022, then tumbled by 204.18% to -$4.7 million in 2023, then jumped by 181.48% to $3.8 million in 2024, then tumbled by 211.28% to -$4.2 million in 2025, then soared by 175.18% to $3.2 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $3.2 million in Q1 2026, -$4.2 million in Q4 2025, and $5.5 million in Q3 2025.